Skip to main content

Advertisement

SpringerLink
Log in

A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution

  • Review
  • Published:
Histochemistry and Cell Biology Aims and scope Submit manuscript

Abstract

Multicellular responses to infection, injury, or inflammatory stimuli lead to the formation and release of a wide range of local chemical mediators by the host. The integrated response of the host is essential in health and disease, thus it is important to achieve a more complete understanding of the local cellular and molecular events that govern the formation and actions of local mediators that can serve as endogenous counter-regulatory functions in effector cells of the immune system or “endogenous local mediators of resolution.” Since these compounds in theory and in experimental models of inflammation appear to control the duration and magnitude of inflammation, knowledge of their elucidation could provide new avenues for appreciating the molecular phenotypes of many inflammatory diseases. The first of these endogenous local counter-regulators recognized were the lipoxins, which are trihydroxytetraene-containing lipid mediators that can be formed during cell–cell interactions via transcellular biosynthesis. Since this circuit of lipoxin formation and action appears to be of physiological relevance for the resolution of inflammation, therapeutic modalities targeted at this system are likely to have fewer unwanted side effects acting as agonists than the inhibitor approach currently used in anti-inflammatory therapies. This chapter provides an overview of the recent knowledge about the biosynthesis and bioactions of the novel anti-inflammatory lipid mediators, resolvins, docosatrienes, and neuroprotectins, and their aspirin-triggered counterparts. These novel families of lipid-derived mediators, which carry anti-inflammatory, pro-resolving, and protective properties, were originally isolated during spontaneous resolution. These new pathways open new opportunities for appreciating the role of neutrophils in the generation of potent protective lipid mediators and protective host signaling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2a, b
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Aliberti J, Sher A (2002) Role of G-protein-coupled signaling in the induction and regulation of dendritic cell function by Toxoplasma gondii. Microbes Infect 4:991–997

    Article  CAS  PubMed  Google Scholar 

  • Aliberti J, Hieny S, Reis e Sousa C, Serhan CN, Sher A (2002a) Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 3:76–82

    Article  CAS  PubMed  Google Scholar 

  • Aliberti J, Serhan C, Sher A (2002b) Parasite-induced lipoxin A(4) is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J Exp Med 196:1253–1262

    Article  CAS  PubMed  Google Scholar 

  • Arita M, Bianchini F, Aliberti J, Sher A, Yang R, Petasis NA, Serhan CN (2003) Novel omega-3 autacoid resolvin E1: receptor identification and anti-inflammatory properties. J Leukoc Biol Suppl: 31(abstract number 72)

    Google Scholar 

  • Bae Y-S, Park JC, He R, Ye RD, Kwak J-Y, Suh P-G, Ryu SH (2003) Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. Mol Pharmacol 63:721–730

    Article  Google Scholar 

  • Bandeira-Melo C, Bozza PT, Diaz BL, Cordeiro RSB, Jose PJ, Martins MA, Serhan CN (2000a) Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol 164:2267–2271

    CAS  PubMed  Google Scholar 

  • Bandeira-Melo C, Serra MF, Diaz BL, Cordeiro RSB, Silva PMR, Lenzi HL, Bakhle YS, Serhan CN, Martins MA (2000b) Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol 164:1029–1036

    CAS  PubMed  Google Scholar 

  • Bannenberg GL, Aliberti J, Hong S, Sher A, Serhan CN (2004) Exogenous pathogen and plant 15-lipoxygenase initiate endogenous lipoxin A4 biosynthesis. J Exp Med 199:515–523

    Article  CAS  PubMed  Google Scholar 

  • Bazan NG (1990) Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman RJ, Wurtman JJ (eds) Nutrition and the brain, vol 8. Raven, New York, pp 1–22

  • Bazan NG (1992) Supply, uptake, and utilization of docosahexaenoic acid during photoreceptor cell differentiation. Nestle Nutrition Workshop Series 28:121–133

    CAS  Google Scholar 

  • Bonnans C, Vachier I, Chavis C, Godard P, Bousquet J, Chanez P (2002) Lipoxins are potential endogenous antiinflammatory mediators in asthma. Am J Respir Crit Care Med 165:1531–1535

    Article  PubMed  Google Scholar 

  • Bonnans C, Mainprice B, Chanez P, Bousquet J, Urbach V (2003) Lipoxin A4 stimulates a cytosolic Ca2+ increase in human bronchial epithelium. J Biol Chem 278:10879–10884

    Article  CAS  PubMed  Google Scholar 

  • Boutet P, Bureau F, Degand G, Lekeux P (2003) Imbalance between lipoxin A4 and leukotriene B4 in chronic mastitis-affected cows. J Dairy Sci 86:3430–3439

    CAS  PubMed  Google Scholar 

  • Brady HR, Papayianni A, Serhan CN (1995) Potential vascular roles for lipoxins in the “stop programs” of host defense and inflammation. Trends Cardiovasc Med 5:186–192

    Article  CAS  Google Scholar 

  • Brezinski DA, Nesto RW, Serhan CN (1992) Angioplasty triggers intracoronary leukotrienes and lipoxin A4. Impact of aspirin therapy. Circulation 86:56–63

    CAS  PubMed  Google Scholar 

  • Burr GO, Burr MM (1929) A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 82:345

    CAS  Google Scholar 

  • Canny G, Levy O, Furuta GT, Narravula-Alipati S, Sisson RB, Serhan CN, Colgan SP (2002) Lipid mediator-induced expression of bactericidal/permeability-increasing protein (BPI) in human mucosal epithelia. Proc Natl Acad Sci U S A 99:3902–3907

    Article  CAS  PubMed  Google Scholar 

  • Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA (2002) Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539–541

    Article  CAS  PubMed  Google Scholar 

  • Chiang N, Takano T, Clish CB, Petasis NA, Tai H-H, Serhan CN (1998) Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther 287:779–790

    CAS  PubMed  Google Scholar 

  • Chiang N, Gronert K, Clish CB, O’Brien JA, Freeman MW, Serhan CN (1999) Leukotriene B4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest 104:309–316

    CAS  PubMed  Google Scholar 

  • Chiang N, Takano T, Arita M, Watanabe S, Serhan CN (2003) A novel rat lipoxin A4 receptor that is conserved in structure and function. Br J Pharmacol 139:89–98

    Article  CAS  PubMed  Google Scholar 

  • Clària J, Serhan CN (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell–leukocyte interactions. Proc Natl Acad Sci U S A 92:9475–9479

    PubMed  Google Scholar 

  • Clish CB, O’Brien JA, Gronert K, Stahl GL, Petasis NA, Serhan CN (1999) Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci U S A 96:8247–8252

    Article  CAS  PubMed  Google Scholar 

  • Clish CB, Levy BD, Chiang N, Tai H-H, Serhan CN (2000) Oxidoreductases in lipoxin A4 metabolic inactivation. J Biol Chem 275:25372–25380

    Article  CAS  PubMed  Google Scholar 

  • Clish CB, Sun YP, Serhan CN (2001) Identification of dual cyclooxygenase-eicosanoid oxidoreductase inhibitors: NSAIDs that inhibit PG-LX reductase/LTB(4) dehydrogenase. Biochem Biophys Res Commun 288:868–874

    Article  CAS  PubMed  Google Scholar 

  • Corey EJ, Shih C, Cashman JR (1983) Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A 80:3581–3584

    CAS  PubMed  Google Scholar 

  • Cotran RS (1982) The endothelium and inflammation: new insights. In: Majno G, Cotran RS, Kaufman N (eds) Current topics in Inflammation and Infection. Williams & Wilkins, Baltimore, pp 18–37

  • Cotran PR, Hsu C, Fokin VV, Petasis NA, Serhan CN (1995a) Lipoxin analogs reduce intraocular pressure in rabbits. International Symposium on Experimental and Clinical Ocular Pharmacology and Pharmaceutics, Geneva, Switzerland

  • Cotran PR, Hsu C, Serhan CN (1995b) Lipoxin derivatives reduce intraocular pressure in rabbits. Association for Research in Vision and Ophthalmology

  • Cotran RS, Kumar V, Collins T (eds) (1999a) Robbins pathologic basis of disease. Saunders, Philadelphia

  • Cotran RS, Kumar V, Collins T (1999b) Cellular pathology I: cell injury and cell death. In: Cotran RS, Kumar V, Collins T (eds) Robbins pathologic basis of disease. Saunders, Philadelphia, pp 1–29

  • Devchand PR, Arita M, Hong S, Bannenberg G, Moussignac R-L, Gronert K, Serhan CN (2003) Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host-defense. FASEB J 17:652–659

    Article  CAS  PubMed  Google Scholar 

  • Drazen JM, Israel E, O’Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340:197–206

    Article  CAS  PubMed  Google Scholar 

  • Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ (2004) C-reactive protein and the risk of incident colorectal cancer. JAMA 291:585–590

    Article  CAS  PubMed  Google Scholar 

  • Fierro IM, Kutok JL, Serhan CN (2002) Novel lipid mediator regulators of endothelial cell proliferation and migration: aspirin-triggered-15R-lipoxin A4 and lipoxin A4. J Pharmacol Exp Ther 300:385–392

    Article  CAS  PubMed  Google Scholar 

  • Fierro IM, Colgan SP, Bernasconi G, Petasis NA, Clish CB, Arita M, Serhan CN (2003) Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 170:2688–2694

    CAS  PubMed  Google Scholar 

  • Fiore S, Ryeom SW, Weller PF, Serhan CN (1992) Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils. J Biol Chem 267:16168–16176

    CAS  PubMed  Google Scholar 

  • Fiore S, Maddox JF, Perez HD, Serhan CN (1994) Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med 180:253–260

    Article  CAS  PubMed  Google Scholar 

  • Fiorucci S, De Lima OM Jr, Mencarelli A, Palazzetti B, Distrutti E, McKnight W, Dicay M, Ma L, Romano M, Morelli A, Wallace JL (2002) Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology 123:1598–1606

    CAS  PubMed  Google Scholar 

  • Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, Wallace JL (2003a) Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipoxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J 17:1171–1173

    CAS  PubMed  Google Scholar 

  • Fiorucci S, Distrutti E, Mencarelli A, Morelli A, Laufler SA, Cirino G, Wallace JL (2003b) Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br J Pharmacol 139:1351–1359

    Article  CAS  PubMed  Google Scholar 

  • Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, Morelli A (2003c) Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci U S A 100:10937–10941

    Article  CAS  PubMed  Google Scholar 

  • Fiorucci S, Distrutti E, Mencarelli A, Rizzo G, Di Lorenzo AR, Baldoni M, del Soldato P, Morelli A, Wallace J (2004) Cooperation between aspirin-triggered lipoxin and nitric oxide (NO) mediates anti-adhesive properties of NCX-4016 (NO-aspirin) on neutrophil-endothelial cell adherence. J Pharmacol Exp Ther 309:1174–1182

    Article  CAS  PubMed  Google Scholar 

  • Flower RJ (1985) Cyclooxygenase inhibitors: an overview. In: Bailey JM (ed) Prostaglandins, leukotrienes and lipoxins: biochemistry, mechanism of action, and clinical applications. Plenum, New York, pp 583–591

  • Flower RJ (2003) The development of COX2 inhibitors. Nat Rev Drug Discov 2:179–191

    Article  CAS  PubMed  Google Scholar 

  • Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O’Sullivan BP (2004) Association of cystic fibrosis with abnormalities in fatty acid metabolism. N Engl J Med 350:560–569

    Article  CAS  PubMed  Google Scholar 

  • Gallin JI, Snyderman R, Fearon DT, Haynes BF, Nathan C (eds) (1999) Inflammation: basic principles and clinical correlates. Lippincott Williams & Wilkins, Philadelphia

  • Gangemi S, Luciotti G, D’Urbano E, Mallamace A, Santoro D, Bellinghieri G, Davi G, Romano M (2003) Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J Appl Physiol 94:2237–2240

    CAS  PubMed  Google Scholar 

  • Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M (2003) Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. Blood 101:4140–4147

    Article  CAS  PubMed  Google Scholar 

  • Gewirtz AT, Madara JL (2000) Lipoxin-stable analogs: potential therapeutic downregulators of intestinal inflammation. Ernst Schering Res Found Workshop 31:187–199

    CAS  PubMed  Google Scholar 

  • Gewirtz AT, Collier-Hyams LS, Young AN, Kucharzik T, Guilford WJ, Parkinson JF, Williams IR, Neish AS, Madara JL (2002) Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 168:5260–5267

    CAS  PubMed  Google Scholar 

  • Gilroy DW, Colville-Nash PR, Willis D, Chivers J, Paul-Clark MJ, Willoughby DA (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5:698–701

    Article  CAS  PubMed  Google Scholar 

  • Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, Croxtall JD (2004) A novel role for phospholipase A2 isoforms in the checkpoint control of acute inflammation. FASEB J 18:489–498

    Article  CAS  PubMed  Google Scholar 

  • GISSI-Prevenzione Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 354:447–455

    Article  PubMed  Google Scholar 

  • Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, Brady HR (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164:1663–1667

    CAS  PubMed  Google Scholar 

  • Goh J, Godson C, Brady HR, MacMathuna P (2003) Lipoxins: pro-resolution lipid mediators in intestinal inflammation. Gastroenterology 124:1043–1054

    CAS  PubMed  Google Scholar 

  • Gronert K, Gewirtz A, Madara JL, Serhan CN (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by IL-13 and IFN-γ and inhibits TNF-α-induced IL-8 release. J Exp Med 187:1285–1294

    Article  CAS  PubMed  Google Scholar 

  • Hamberg M, Samuelsson B (1967) On the specificity of the oxygenation of unsaturated fatty acids catalyzed by soybean lipoxidase. J Biol Chem 242:5329–5335

    CAS  PubMed  Google Scholar 

  • Hamberg M, Sanz A, Rodriguez MJ, Calvo AP, Castresana C (2003) Activation of the fatty acid α-dioxygenase pathway during bacterial infection of tobacco leaves. J Biol Chem 278:51796–51805

    Article  CAS  PubMed  Google Scholar 

  • He R, Sang H, Ye RD (2003) Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 101:1572–1581

    Article  CAS  PubMed  Google Scholar 

  • Heasman SJ, Giles KM, Ward C, Rossi AG, Haslett C, Dransfield I (2003) Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol 178:29–36

    CAS  PubMed  Google Scholar 

  • Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Godmundsson G, Grant SFA, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir A, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239

    Article  CAS  PubMed  Google Scholar 

  • Hong S, Gronert K, Devchand P, Moussignac R-L, Serhan CN (2003) Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J Biol Chem 278:14677–14687

    Article  CAS  PubMed  Google Scholar 

  • Jackson LM, Hawkey CJ (2000) COX-2 selective nonsteroidal anti-inflammatory drugs: do they really offer any advantages? Drugs 59:1207–1216

    CAS  PubMed  Google Scholar 

  • Kang Y, Taddeo B, Varai G, Varga J, Fiore S (2000) Mutations of serine 235–237 and tyrosine 302 residues in the human lipoxin A4 receptor intracellular domains result in sustained signaling. Biochemistry 39:13551–13557

    Google Scholar 

  • Kang JX, Wang J, Wu L, Kang ZB (2004) Fat-1 mice convert n-6 to n-3 fatty acids. Nature 427:504

    Article  CAS  PubMed  Google Scholar 

  • Kantarci A, Van Dyke TE (2003) Lipoxins in chronic inflammation. Crit Rev Oral Biol Med 14:4–12

    PubMed  Google Scholar 

  • Kieran NE, Doran PP, Connolly SB, Greenan M-C, Higgins DF, Leonard M, Godson C, Taylor CT, Henger A, Kretzler M, Burne MJ, Rabb H, Brady HR (2003) Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int 64:480–492

    Article  CAS  PubMed  Google Scholar 

  • Kowalski ML, Ptasinska A, Bienkiewicz B, Pawliczak R, DuBuske L (2003) Differential effects of aspirin and misoprostol on 15-hydroxyeicosatetraenoic acid generation by leukocytes from aspirin-sensitive asthmatic patients. J Allergy Clin Immunol 112:505–512

    Article  CAS  PubMed  Google Scholar 

  • Kucharzik T, Gewirtz AT, Merlin D, Madara JL, Williams IR (2003) Lateral membrane LXA4 receptors mediate LXA4’s anti-inflammatory actions on intestinal epithelium. Am J Physiol Cell Physiol 284:C888–C896

    CAS  PubMed  Google Scholar 

  • Lands WEM (ed) (1987) Proceedings of the AOCS short course on polyunsaturated fatty acids and eicosanoids. American Oil Chemists’ Society, Champaign, IL

  • Lands WEM (2003) Diets could prevent many diseases. Lipids 38:317–321

    CAS  PubMed  Google Scholar 

  • Lawrence T, Willoughby DA, Gilroy DW (2002) Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2:787–795

    Article  CAS  PubMed  Google Scholar 

  • Lee TH, Mencia-Huerta J-M, Shih C, Corey EJ, Lewis RA, Austen KF (1984) Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74:1922–1933

    CAS  PubMed  Google Scholar 

  • Lehr H-A, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hübner C, Berndt MC, Steinberg D, Messmer K, Arfors KE (1994) P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 71:380–386

    CAS  PubMed  Google Scholar 

  • Leonard MO, Hannan K, Burne MJ, Lappin DW, Doran P, Coleman P, Stenson C, Taylor CT, Daniels F, Godson C, Petasis NA, Rabb H, Brady HR (2002) 15-Epi-16-(para-fluorophenoxy)-lipoxin A4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure. J Am Soc Nephrol 13:1657–1662

    CAS  PubMed  Google Scholar 

  • Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nature Immunol 2:612–619

    Article  CAS  Google Scholar 

  • Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA, Szczeklik W, Drazen JM, Serhan CN (2002) Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. Nat Med 8:1018–1023

    Article  CAS  PubMed  Google Scholar 

  • Levy O, Canny G, Serhan CN, Colgan SP (2003) Expression of BPI (bactericidal/permeability-increasing protein) in human mucosal epithelia. Biochem Soc Trans 31:795–800

    Google Scholar 

  • Lu Y, Hong S, Tjonahen E, Serhan CN (2003) Lipid mediator lipidomics: databases and search algorithms of electric spray ionization/tandem mass and ultraviolet spectra for structural elucidation. 5th Winter Eicosanoid Conference, Baltimore

    Google Scholar 

  • Maddox JF, Serhan CN (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183:137–146

    Article  CAS  PubMed  Google Scholar 

  • Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN (1997) Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein linked lipoxin A4 receptor. J Biol Chem 272:6972–6978

    Article  CAS  PubMed  Google Scholar 

  • Maderna P, Cottell DC, Berlasconi G, Petasis NA, Brady HR, Godson C (2002) Lipoxins induce actin reorganization in monocytes and macrophages but not in neutrophils: differential involvement of rho GTPases. Am J Pathol 160:2275–2283

    CAS  PubMed  Google Scholar 

  • Majno G (1975) The healing hand: man and wound in the ancient world. Harvard University Press, Cambridge

    Google Scholar 

  • Majno G (1982) Inflammation and infection: historic highlights. In: Majno G, Cotran RS, Kaufman N (eds) Current topics in inflammation and infection. Williams & WIlkins, Baltimore, pp 1–17

  • Mamdani M, Rochon P, Juurlink DN, Anderson GM, Kopp A, Naglie G, Austin PC, Laupacis A (2003) Effect of selective cyclooxygenase 2 inhibitors and naproxen on short-tem risk of acute myocardial infarction in the elderly. Arch Intern Med 163:481–486

    Article  CAS  PubMed  Google Scholar 

  • Marcheselli VL, Hong S, Lukiw WJ, Hua Tian X, Gronert K, Musto A, Hardy M, Gimenez JM, Chiang N, Serhan CN, Bazan NG (2003) Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278:43807–43817

    Article  CAS  PubMed  Google Scholar 

  • Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897–1903

    Article  CAS  PubMed  Google Scholar 

  • Marcus AJ (1999) Platelets: their role in hemostasis, thrombosis, and inflammation. In: Gallin JI, Snyderman R (eds) Inflammation: basic principles and clinical correlates. Lippincott Williams & Wilkins, Philadelphia, pp 77–95

  • McMahon B, Stenson C, McPhillips F, Fanning A, Brady HR, Godson C (2000) Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells: differential activation of MAP kinases through distinct receptors. J Biol Chem 275:27566–27575

    CAS  PubMed  Google Scholar 

  • McMahon B, Mitchell S, Brady HR, Godson C (2001) Lipoxins: revelations on resolution. Trends Pharmacol Sci 22:391–395

    Article  CAS  PubMed  Google Scholar 

  • McMahon B, Mitchell D, Shattock R, Martin F, Brady HR, Godson C (2002) Lipoxin, leukotriene, and PDGF receptors cross-talk to regulate mesangial cell proliferation. FASEB J 16:1817–1819

    CAS  PubMed  Google Scholar 

  • Mengle-Gaw LJ, Schwartz BD (2002) Cyclooxygenase-2 inhibitors: promise or peril? Mediators Inflamm 11:275–286

    Article  CAS  PubMed  Google Scholar 

  • Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, Petasis NA, Erwig L, Rees AJ, Savill J, Brady HR, Godson C (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13:2497–2507

    CAS  PubMed  Google Scholar 

  • Mora JR, Bono MR, Manjunath N, Weninger W, Cavanagh LL, Rosenmblatt M, von Andrian UH (2003) Selective imprinting of gut-homing T cells by Peyer’s patch dendritic cells. Nature 424:88–93

    Article  CAS  PubMed  Google Scholar 

  • Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG (2004) Neuroprotectin D1 a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101:8491–8496

    Article  CAS  PubMed  Google Scholar 

  • Munger KA, Montero A, Fukunaga M, Uda S, Yura T, Imai E, Kaneda Y, Valdivielso JM, Badr KF (1999) Transfection of rat kidney with human 15-lipoxygenase suppresses inflammation and preserves function in experimental glomerulonephritis. Proc Natl Acad Sci U S A 96:13375–13380

    Article  CAS  PubMed  Google Scholar 

  • Murphy FJ, Hayes I, Cotter TG (2003) Targeting inflammatory diseases via apoptotic mechanisms. Curr Opin Phamacol 3:412–419

    Article  CAS  Google Scholar 

  • Nathan C (2002) Points of control in inflammation. Nature 420:846–852

    Article  CAS  PubMed  Google Scholar 

  • Navia MA, Peattie DA (1993) Structure-based drug design: applications in immunopharmacology and immunosuppression. Trends Pharmacol Sci 14:189–195

    Article  CAS  PubMed  Google Scholar 

  • Pasche B, Serhan CN (2004) Is C-reactive protein an inflammation opsonin that signals colon cancer risk? JAMA 291:623–624

    Article  CAS  PubMed  Google Scholar 

  • Perretti M, Chiang N, La M, Fierro IM, Marullo S, Getting SJ, Solito E, Serhan CN (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat Med 8:1296–1302

    Article  CAS  PubMed  Google Scholar 

  • Planagumà A, Titos E, López-Parra M, Gaya J, Pueyo G, Arroyo V, Clària J (2002) Aspirin (ASA) regulates 5-lipoxygenase activity and peroxisome proliferator-activated receptor α-mediated CINC-1 release in rat liver cells: novel actions of lipoxin A4 (LXA4) and ASA-triggered 15-epi-LXA4. FASEB J 16:1937–1939

    PubMed  Google Scholar 

  • Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN (2000) Lipoxin A4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 39:4761–4768

    Google Scholar 

  • Qiu F-H, Devchand PR, Wada K, Serhan CN (2001) Aspirin-triggered lipoxin A4 and lipoxin A4 up-regulate transcriptional corepressor NAB1 in human neutrophils. FASEB J 15:2736–2738

    CAS  PubMed  Google Scholar 

  • Reich EE, Zackert WE, Brame CJ, Chen Y, Roberts LJ II, Hachey DL, Montine TJ, Morrow JD (2000) Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry 39:2376–2383

    Google Scholar 

  • Romano M, Luciotti G, Gangemi S, Marinucci F, Prontera C, D’Urbano E, Davi G (2002) Urinary excretion of lipoxin A4 and related compounds: development of new extraction techniques for lipoxins. Lab Invest 82:1253–1254

    CAS  PubMed  Google Scholar 

  • Rosenstein ED, Kushner LJ, Kramer N, Kazandjian G (2003) Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids 68:213–218

    Article  CAS  PubMed  Google Scholar 

  • Rowley AF, Lloyd-Evans P, Barrow SE, Serhan CN (1994) Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry 33:856–863

    Google Scholar 

  • Salem N Jr, Litman B, Kim H-Y, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945–959

    CAS  PubMed  Google Scholar 

  • Samuelsson B (1982) From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures. Almqvist & Wiksell, Stockholm, pp 153–174

    Google Scholar 

  • Samuelsson B, Dahlén SE, Lindgren JÅ, Rouzer CA, Serhan CN (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171–1176

    CAS  PubMed  Google Scholar 

  • Sanak M, Levy BD, Clish CB, Chiang N, Gronert K, Mastalerz L, Serhan CN, Szczeklik A (2000) Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J 16:44–49

    Article  CAS  PubMed  Google Scholar 

  • Sawazaki S, Salem N Jr, Kim H-Y (1994) Lipoxygenation of docosahexaenoic acid by the rat pineal body. J Neurochem 62:2437–2447

    CAS  PubMed  Google Scholar 

  • Schottelius AJ, Giesen C, Asadullah K, Fierro IM, Colgan SP, Bauman J, Guilford W, Perez HD, Parkinson JF (2002) An aspirin-triggered lipoxin A4 stable analog displays a unique topical anti-inflammatory profile. J Immunol 169:7063–7070

    CAS  PubMed  Google Scholar 

  • Serhan CN (1994) Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1212:1–25

    Google Scholar 

  • Serhan CN (1997) Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell–cell interactions or a therapeutic opportunity? Prostaglandins 53:107–137

    Article  CAS  PubMed  Google Scholar 

  • Serhan CN (2002) Endogenous chemical mediators in anti-inflammation and pro-resolution. Curr Med Chem Anti-Inflammatory Anti-Allergy Agents 1:177–192

  • Serhan CN, Oliw E (2001) Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107:1481–1489

    CAS  PubMed  Google Scholar 

  • Serhan CN, Sheppard KA (1990) Lipoxin formation during human neutrophil–platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest 85:772–780

    CAS  PubMed  Google Scholar 

  • Serhan CN, Ward PA (eds) (1999) Molecular and cellular basis of inflammation. Humana, Totowa, NJ

  • Serhan CN, Broekman MJ, Korchak HM, Smolen JE, Marcus AJ, Weissmann G (1983) Changes in phosphatidylinositol and phosphatidic acid in stimulated human neutrophils. Relationship to calcium mobilization, aggregation and superoxide radical generation. Biochim Biophys Acta 762:420–428

    Article  CAS  PubMed  Google Scholar 

  • Serhan CN, Hamberg M, Samuelsson B (1984) Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A 81:5335–5339

    CAS  PubMed  Google Scholar 

  • Serhan CN, Fiore S, Brezinski DA, Lynch S (1993) Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 32:6313–6319

    Google Scholar 

  • Serhan CN, Maddox JF, Petasis NA, Akritopoulou-Zanze I, Papayianni A, Brady HR, Colgan SP, Madara JL (1995) Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34:14609–14615

    Google Scholar 

  • Serhan CN, Clish CB, Brannon J, Colgan SP, Chiang N, Gronert K (2000) Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192:1197–1204

    Article  CAS  PubMed  Google Scholar 

  • Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, Mirick G, Moussignac R-L (2002) Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 196:1025–1037

    Article  CAS  PubMed  Google Scholar 

  • Serhan CN, Jain A, Marleau S, Clish C, Kantarci A, Behbehani B, Colgan SP, Stahl GL, Merched A, Petasis NA, Chan L, Van Dyke TE (2003) Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171:6856–6865

    CAS  PubMed  Google Scholar 

  • Simopoulos AP, Leaf A, Salem N Jr (1999) Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 18:487–489

    CAS  PubMed  Google Scholar 

  • Souza MH, de Lima OM Jr, Zamuner SR, Fiorucci S, Wallace JL (2003) Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am J Physiol Gastrointest Liver Physiol 285:G54–G61

    CAS  PubMed  Google Scholar 

  • Takano T, Fiore S, Maddox JF, Brady HR, Petasis NA, Serhan CN (1997) Aspirin-triggered 15-epi-lipoxin A4 and LXA4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 185:1693–1704

    Article  CAS  PubMed  Google Scholar 

  • Takano T, Clish CB, Gronert K, Petasis N, Serhan CN (1998) Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues. J Clin Invest 101:819–826

    CAS  PubMed  Google Scholar 

  • Tauber AI, Chernyak L (1991) Metchnikoff and the origins of immunology: from metaphor to theory. Oxford University Press, New York

    Google Scholar 

  • Titos E, Chiang N, Serhan CN, Romano M, Gaya J, Pueyo G, Clària J (1999) Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A4 (ATL). Am J Physiol 277: C870–C877

    CAS  PubMed  Google Scholar 

  • Vachier I, Chanez P, Bonnans C, Godard P, Bousquet J, Chavis C (2002) Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem Biophys Res Commun 290:219–224

    Article  CAS  PubMed  Google Scholar 

  • Vance RE, Hong S, Gronert K, Serhan CN, Mekalanos JJ (2004) The opportunistic pathogen Pseudomonas aeruginosa carries a novel secretable arachidonate 15-lipoxygenase. Proc Natl Acad Sci U S A 101:2135–2139

    Article  CAS  PubMed  Google Scholar 

  • Van Dyke TE, Serhan CN (2003) Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82:82–90

    PubMed  Google Scholar 

  • Vane JR (1982) Adventures and excursions in bioassay: the stepping stones to prostacyclin. Les Prix Nobel: Nobel Prizes, Presentations, Biographies and Lectures. Almqvist & Wiksell, Stockholm, pp 181–206

    Google Scholar 

  • Vane JR (2002) Back to an aspirin a day? Science 296:474–475

    Article  CAS  PubMed  Google Scholar 

  • VanRollins M, Baker RC, Sprecher HW, Murphy RC (1984) Oxidation of docosahexaenoic acid by rat liver microsomes. J Biol Chem 259:5776–5783

    CAS  PubMed  Google Scholar 

  • Vaughn MW, Proske RJ, Haviland DL (2002) Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene. J Immunol 169:3363–3369

    CAS  PubMed  Google Scholar 

  • Wallace JL, Fiorucci S (2003) A magic bullet for mucosal protection . . . and aspirin is the trigger! Trends Pharmacol Sci 24:323–326

  • Wallace JL, Zumuner SR, McKnight W, Dicay M, Mencarelli A, del Soldato P, Fiorucci S (2004) Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation. Am J Physiol Gastrointest Liver Physiol 286:G76–G81

    Article  CAS  PubMed  Google Scholar 

  • Weissmann G, Smolen JE, Korchak HM (1980) Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 303:27–34

    CAS  PubMed  Google Scholar 

  • Winyard PG, Willoughby DA (eds) (2003) Inflammation protocols. Methods in molecular biology. Humana, Totowa, NJ

  • Yopp AC, Randolph GJ, Bromberg JS (2003) Leukotrienes, sphingolipids, and leukocyte trafficking. J Immunol 171:5–10

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Mary Halm Small for assistance in preparing the manuscript. This work was supported in part by National Institutes of Health grants R37-GM38675, P01-DK50305, and P01-DE13499.

Author information

Authors and Affiliations

  1. Center for Experimental Therapeutics and Reperfusion Injury, Thorn Building for Medical Research, Room 724, Brigham and Women’s Hospital, 75 Francis Street, Boston, MA 02115, USA

    Charles N. Serhan

  2. Harvard Medical School, Boston, USA

    Charles N. Serhan

Authors
  1. Charles N. Serhan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles N. Serhan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serhan, C.N. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 122, 305–321 (2004). https://doi.org/10.1007/s00418-004-0695-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00418-004-0695-8

Keywords

Search

Navigation